Blood Coagulants Market
1 Study Coverage
1.1 Blood Coagulants Product Introduction
1.2 Global Blood Coagulants Outlook 2017 VS 2022 VS 2028
1.2.1 Global Blood Coagulants Sales in US$ Million for the Year 2017-2028
1.2.2 Global Blood Coagulants Sales in Volume for the Year 2017-2028
1.3 United States Blood Coagulants Outlook 2017 VS 2022 VS 2028
1.3.1 United States Blood Coagulants Sales in US$ Million for the Year 2017-2028
1.3.2 United States Blood Coagulants Sales in Volume for the Year 2017-2028
1.4 Blood Coagulants Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Blood Coagulants in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Blood Coagulants Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Blood Coagulants Market Dynamics
1.5.1 Blood Coagulants Industry Trends
1.5.2 Blood Coagulants Market Drivers
1.5.3 Blood Coagulants Market Challenges
1.5.4 Blood Coagulants Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Blood Coagulants Market Segment by Type
2.1.1 Recombinant Coagulation Factor
2.1.2 Plasma Coagulation Factor
2.2 Global Blood Coagulants Market Size by Type
2.2.1 Global Blood Coagulants Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Blood Coagulants Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Blood Coagulants Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Blood Coagulants Market Size by Type
2.3.1 United States Blood Coagulants Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Blood Coagulants Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Blood Coagulants Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Sale Channel
3.1 Blood Coagulants Market Segment by Sale Channel
3.1.1 Hospital
3.1.2 Pharmacy
3.1.3 Other
3.2 Global Blood Coagulants Market Size by Sale Channel
3.2.1 Global Blood Coagulants Sales in Value, by Sale Channel (2017, 2022 & 2028)
3.2.2 Global Blood Coagulants Sales in Volume, by Sale Channel (2017, 2022 & 2028)
3.3.3 Global Blood Coagulants Average Selling Price (ASP) by Sale Channel (2017, 2022 & 2028)
3.3 United States Blood Coagulants Market Size by Sale Channel
3.3.1 United States Blood Coagulants Sales in Value, by Sale Channel (2017, 2022 & 2028)
3.3.2 United States Blood Coagulants Sales in Volume, by Sale Channel (2017, 2022 & 2028)
3.3.3 United States Blood Coagulants Average Selling Price (ASP) by Sale Channel (2017, 2022 & 2028)
4 Global Blood Coagulants Competitor Landscape by Company
4.1 Global Blood Coagulants Market Size by Company
4.1.1 Top Global Blood Coagulants Manufacturers Ranked by Revenue (2021)
4.1.2 Global Blood Coagulants Revenue by Manufacturer (2017-2022)
4.1.3 Global Blood Coagulants Sales by Manufacturer (2017-2022)
4.1.4 Global Blood Coagulants Price by Manufacturer (2017-2022)
4.2 Global Blood Coagulants Concentration Ratio (CR)
4.2.1 Blood Coagulants Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Blood Coagulants in 2021
4.2.3 Global Blood Coagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Blood Coagulants Manufacturing Base Distribution, Product Type
4.3.1 Global Blood Coagulants Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Blood Coagulants Product Type
4.3.3 Date of International Manufacturers Enter into Blood Coagulants Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Blood Coagulants Market Size by Company
4.5.1 Top Blood Coagulants Players in United States, Ranked by Revenue (2021)
4.5.2 United States Blood Coagulants Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Blood Coagulants Sales by Players (2020, 2021 & 2022)
5 Global Blood Coagulants Market Size by Region
5.1 Global Blood Coagulants Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Blood Coagulants Market Size in Volume by Region (2017-2028)
5.2.1 Global Blood Coagulants Sales in Volume by Region: 2017-2022
5.2.2 Global Blood Coagulants Sales in Volume Forecast by Region (2023-2028)
5.3 Global Blood Coagulants Market Size in Value by Region (2017-2028)
5.3.1 Global Blood Coagulants Sales in Value by Region: 2017-2022
5.3.2 Global Blood Coagulants Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Blood Coagulants Market Size YoY Growth 2017-2028
6.1.2 North America Blood Coagulants Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Blood Coagulants Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Blood Coagulants Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Blood Coagulants Market Size YoY Growth 2017-2028
6.3.2 Europe Blood Coagulants Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Blood Coagulants Market Size YoY Growth 2017-2028
6.4.2 Latin America Blood Coagulants Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Blood Coagulants Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Blood Coagulants Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Blood Coagulants Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Blood Coagulants Products Offered
7.1.5 Pfizer Recent Development
7.2 Bayer
7.2.1 Bayer Corporation Information
7.2.2 Bayer Description and Business Overview
7.2.3 Bayer Blood Coagulants Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bayer Blood Coagulants Products Offered
7.2.5 Bayer Recent Development
7.3 Novo Nordisk
7.3.1 Novo Nordisk Corporation Information
7.3.2 Novo Nordisk Description and Business Overview
7.3.3 Novo Nordisk Blood Coagulants Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novo Nordisk Blood Coagulants Products Offered
7.3.5 Novo Nordisk Recent Development
7.4 Takeda
7.4.1 Takeda Corporation Information
7.4.2 Takeda Description and Business Overview
7.4.3 Takeda Blood Coagulants Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Takeda Blood Coagulants Products Offered
7.4.5 Takeda Recent Development
7.5 SOBI
7.5.1 SOBI Corporation Information
7.5.2 SOBI Description and Business Overview
7.5.3 SOBI Blood Coagulants Sales, Revenue and Gross Margin (2017-2022)
7.5.4 SOBI Blood Coagulants Products Offered
7.5.5 SOBI Recent Development
7.6 Octapharma
7.6.1 Octapharma Corporation Information
7.6.2 Octapharma Description and Business Overview
7.6.3 Octapharma Blood Coagulants Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Octapharma Blood Coagulants Products Offered
7.6.5 Octapharma Recent Development
7.7 CSL
7.7.1 CSL Corporation Information
7.7.2 CSL Description and Business Overview
7.7.3 CSL Blood Coagulants Sales, Revenue and Gross Margin (2017-2022)
7.7.4 CSL Blood Coagulants Products Offered
7.7.5 CSL Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Blood Coagulants Industry Chain Analysis
8.2 Blood Coagulants Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Blood Coagulants Distributors
8.3 Blood Coagulants Production Mode & Process
8.4 Blood Coagulants Sales and Marketing
8.4.1 Blood Coagulants Sales Channels
8.4.2 Blood Coagulants Distributors
8.5 Blood Coagulants Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Blood Coagulants CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Blood Coagulants Market Trends
Table 3. Blood Coagulants Market Drivers
Table 4. Blood Coagulants Market Challenges
Table 5. Blood Coagulants Market Restraints
Table 6. Global Blood Coagulants Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Blood Coagulants Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Blood Coagulants Sales by Sale Channel: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Blood Coagulants Sales by Sale Channel: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Blood Coagulants Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Blood Coagulants Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Blood Coagulants Revenue Share by Manufacturer, 2017-2022
Table 13. Global Blood Coagulants Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Blood Coagulants Sales Share by Manufacturer, 2017-2022
Table 15. Global Blood Coagulants Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Blood Coagulants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Blood Coagulants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Coagulants as of 2021)
Table 18. Top Players of Blood Coagulants in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Blood Coagulants Product Type
Table 20. Date of International Manufacturers Enter into Blood Coagulants Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Blood Coagulants Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Blood Coagulants Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Blood Coagulants Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Blood Coagulants Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Blood Coagulants Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Blood Coagulants Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Blood Coagulants Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Blood Coagulants Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Blood Coagulants Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Blood Coagulants Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Blood Coagulants Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Blood Coagulants Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Blood Coagulants Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Blood Coagulants Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Blood Coagulants Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Blood Coagulants Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Blood Coagulants Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Blood Coagulants Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Blood Coagulants Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Blood Coagulants Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Pfizer Blood Coagulants Product
Table 46. Pfizer Recent Development
Table 47. Bayer Corporation Information
Table 48. Bayer Description and Business Overview
Table 49. Bayer Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Bayer Product
Table 51. Bayer Recent Development
Table 52. Novo Nordisk Corporation Information
Table 53. Novo Nordisk Description and Business Overview
Table 54. Novo Nordisk Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Novo Nordisk Product
Table 56. Novo Nordisk Recent Development
Table 57. Takeda Corporation Information
Table 58. Takeda Description and Business Overview
Table 59. Takeda Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Takeda Product
Table 61. Takeda Recent Development
Table 62. SOBI Corporation Information
Table 63. SOBI Description and Business Overview
Table 64. SOBI Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. SOBI Product
Table 66. SOBI Recent Development
Table 67. Octapharma Corporation Information
Table 68. Octapharma Description and Business Overview
Table 69. Octapharma Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Octapharma Product
Table 71. Octapharma Recent Development
Table 72. CSL Corporation Information
Table 73. CSL Description and Business Overview
Table 74. CSL Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. CSL Product
Table 76. CSL Recent Development
Table 77. Key Raw Materials Lists
Table 78. Raw Materials Key Suppliers Lists
Table 79. Blood Coagulants Customers List
Table 80. Blood Coagulants Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Coagulants Product Picture
Figure 2. Global Blood Coagulants Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Blood Coagulants Market Size 2017-2028 (US$ Million)
Figure 4. Global Blood Coagulants Sales 2017-2028 (K Units)
Figure 5. United States Blood Coagulants Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Blood Coagulants Market Size 2017-2028 (US$ Million)
Figure 7. United States Blood Coagulants Sales 2017-2028 (K Units)
Figure 8. United States Blood Coagulants Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Blood Coagulants Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Blood Coagulants Report Years Considered
Figure 11. Product Picture of Recombinant Coagulation Factor
Figure 12. Product Picture of Plasma Coagulation Factor
Figure 13. Global Blood Coagulants Market Share by Type in 2022 & 2028
Figure 14. Global Blood Coagulants Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Blood Coagulants Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Blood Coagulants Sales by Type (2017-2028) & (K Units)
Figure 17. Global Blood Coagulants Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Blood Coagulants Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Blood Coagulants Market Share by Type in 2022 & 2028
Figure 20. United States Blood Coagulants Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Blood Coagulants Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Blood Coagulants Sales by Type (2017-2028) & (K Units)
Figure 23. United States Blood Coagulants Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Blood Coagulants Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Hospital
Figure 26. Product Picture of Pharmacy
Figure 27. Product Picture of Other
Figure 28. Global Blood Coagulants Market Share by Sale Channel in 2022 & 2028
Figure 29. Global Blood Coagulants Sales in Value by Sale Channel (2017-2028) & (US$ Million)
Figure 30. Global Blood Coagulants Sales Market Share in Value by Sale Channel (2017-2028)
Figure 31. Global Blood Coagulants Sales by Sale Channel (2017-2028) & (K Units)
Figure 32. Global Blood Coagulants Sales Market Share in Volume by Sale Channel (2017-2028)
Figure 33. Global Blood Coagulants Price by Sale Channel (2017-2028) & (USD/Unit)
Figure 34. United States Blood Coagulants Market Share by Sale Channel in 2022 & 2028
Figure 35. United States Blood Coagulants Sales in Value by Sale Channel (2017-2028) & (US$ Million)
Figure 36. United States Blood Coagulants Sales Market Share in Value by Sale Channel (2017-2028)
Figure 37. United States Blood Coagulants Sales by Sale Channel (2017-2028) & (K Units)
Figure 38. United States Blood Coagulants Sales Market Share in Volume by Sale Channel (2017-2028)
Figure 39. United States Blood Coagulants Price by Sale Channel (2017-2028) & (USD/Unit)
Figure 40. North America Blood Coagulants Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Blood Coagulants Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Blood Coagulants Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Blood Coagulants Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Blood Coagulants Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Blood Coagulants Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Blood Coagulants Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Blood Coagulants Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Blood Coagulants Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Blood Coagulants Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Blood Coagulants Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Blood Coagulants Value Chain
Figure 74. Blood Coagulants Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Industry Market Size
